We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$37.8B
AUM Growth
+$1.43B
Cap. Flow
+$830M
Cap. Flow %
2.19%
Top 10 Hldgs %
20.38%
Holding
4,005
New
290
Increased
1,922
Reduced
1,528
Closed
192

Sector Composition

Rank Sector Weight
1 Technology 12.27%
2 Financials 5.07%
3 Consumer Discretionary 3.53%
4 Communication Services 3.12%
5 Industrials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NRO
3751
Neuberger Real Estate Securities Income Fund Inc
NRO
$188M
$55K ﹤0.01%
18,129
+1,109
+7% +$3.43K
ANNX icon
3752
Annexon
ANNX
$873M
$54K ﹤0.01%
10,700
VERI icon
3753
Veritone
VERI
$141M
$52K ﹤0.01%
+11,193
New +$60.2K
QNCX icon
3754
Quince Therapeutics
QNCX
$31.8M
$51K ﹤0.01%
76
CHMI
3755
Cherry Hill Mortgage Investment Corp
CHMI
$107M
$49K ﹤0.01%
19,389
-2,963
-13% -$7.22K
CRON
3756
Cronos Group
CRON
$1.17B
$49K ﹤0.01%
18,703
-3,600
-16% -$9.31K
CIF
3757
DELISTED
MFS Intermediate High Income Fund
CIF
$47K ﹤0.01%
27,464
+2,500
+10% +$4.33K
PTLO icon
3758
Portillo's
PTLO
$345M
$47K ﹤0.01%
10,348
-3,175
-23% -$16.6K
SLS icon
3759
SELLAS Life Sciences
SLS
$2.31B
$47K ﹤0.01%
12,435
-7,565
-38% -$14.7K
ABSI icon
3760
Absci
ABSI
$1.61B
$45K ﹤0.01%
+12,875
New +$46.9K
EPM icon
3761
Evolution Petroleum
EPM
$134M
$44K ﹤0.01%
12,300
ONL
3762
Orion Office REIT
ONL
$161M
$44K ﹤0.01%
19,685
-2,401
-11% -$5.66K
FUFU icon
3763
BitFuFu
FUFU
$217M
$44K ﹤0.01%
+16,713
New +$53K
DHF
3764
BNY Mellon High Yield Strategies Fund
DHF
$175M
$42K ﹤0.01%
+17,019
New +$43.2K
LWLG icon
3765
Lightwave Logic
LWLG
$1.23B
$42K ﹤0.01%
13,021
+60
+0.5% +$266
QSI icon
3766
Quantum-Si Incorporated
QSI
$182M
$42K ﹤0.01%
37,767
-1,100
-3% -$1.79K
JELD icon
3767
JELD-WEN Holding
JELD
$164M
$39K ﹤0.01%
15,666
+525
+3% +$1.72K
CLOV icon
3768
Clover Health Investments
CLOV
$2.41B
$38K ﹤0.01%
16,001
-2,000
-11% -$5.47K
DOUG icon
3769
Douglas Elliman
DOUG
$184M
$37K ﹤0.01%
15,748
-8,236
-34% -$21.2K
MDXH icon
3770
MDxHealth
MDXH
$24.1M
$36K ﹤0.01%
+10,000
New +$39.5K
KOPN icon
3771
Kopin
KOPN
$930M
$35K ﹤0.01%
15,051
+71
+0.5% +$205
HRTX icon
3772
Heron Therapeutics
HRTX
$64.7M
$34K ﹤0.01%
26,422
-200
-0.8% -$247
OXSQ icon
3773
Oxford Square Capital
OXSQ
$166M
$34K ﹤0.01%
19,322
EVGO icon
3774
EVgo
EVGO
$497M
$33K ﹤0.01%
11,498
-1,696
-13% -$6.16K
GEVO icon
3775
Gevo
GEVO
$391M
$33K ﹤0.01%
16,353

Similar funds

Cambridge Investment Research Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Cambridge Investment Research Advisors held 4,005 positions worth $37.8B, up 3.9% from $36.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q4 2025 filing shows 290 new, 1,922 increased, 1,528 reduced and 192 closed positions. Its largest new stake was Akre Focus ETF: 1,072,509 shares worth $70.3M. The largest sale was Invesco NASDAQ 100 ETF, an estimated $85.8M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q4 2025 buy was Akre Focus ETF: 1,072,509 shares worth $70.3M.
  • Cambridge Investment Research Advisors added most to Invesco Ultra Short Duration ETF in Q4 2025, an estimated $67M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2025 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $85.8M.
  • Cambridge Investment Research Advisors fully exited iShares 0-1 Year Treasury Bond ETF in Q4 2025, selling an estimated $24.7M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $37.8B portfolio in Q4 2025.
  • Cambridge Investment Research Advisors opened 290 new positions and closed 192 in Q4 2025.
  • Cambridge Investment Research Advisors's portfolio value rose 3.9% quarter-over-quarter to $37.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2025, filed 5 Feb 2026.